Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent
Abstract
We studied the possibility of using BSA-coated magnetic iron oxide nanoparticles for magnetic resonance imaging diagnosis of C6 glioblastoma, 4T1 mammary adenocarcinoma, and RS-1 hepatic mucous carcinoma. In all three cases, magnetic nanoparticles accumulated in the tumor and its large vessels. Magnetic resonance imaging with contrast agent allows visualization of the tumor tissue and its vascularization.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The magnetic nanosystem can be used as a nano-scale imaging probe, which contributes to early diagnosis.
“In addition, the magnetic nanosystem can be used as a nano-scale imaging probe, which contributes to early diagnosis.189”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [189]
Cites
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376 · see citing works
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,467 · see citing works
Disruption of astrocyte–vascular coupling and the blood–brain barrier by invading glioma cells
Watkins, S., Robel, S., Kimbrough, I. F., Robert, S. M., Ellis‐Davies, G. C. R., & Sontheimer, H. W. (2014) · Nature Communications · doi:10.1038/ncomms5196 · Cited by 551 · see citing works
Magnetic Nanoparticles in Cancer Theranostics
Gobbo, O. L., Sjaastad, K., Radomski, M. W., Volkov, Y., & Prina‐Mello, A. (2015) · Theranostics · doi:10.7150/thno.11544 · Cited by 462 · see citing works
Huang, J., Bu, L., Xie, J., Chen, K., Cheng, Z., Li, X., & Chen, X. S. (2010) · ACS Nano · doi:10.1021/nn101643u · Cited by 461 · see citing works
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., OʼReilly, M., Christofori, G., Holmgren, L., Grosfeld, J. A., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 343 · see citing works
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma
Tanimoto, A., & Kuribayashi, S. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2005.11.040 · Cited by 131 · see citing works
Semkina, A. S., Abakumov, M. A., Grinenko, N. F., Abakumov, A. M., Skorikov, A. S., Mironova, E. A., Davydova, G. A., Majouga, A. G., Nukolova, N. V., Kabanov, A. V., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.11.009 · Cited by 71 · see citing works
Self-citationNovel membrane-permeable contrast agent for brain tumor detection by MRI
Kumar, M., Medarova, Z. O., Pantazopoulos, P., et al. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22216 · Cited by 35 · see citing works
Semkina, A. S., Abakumov, M. A., Abakumov, A. M., et al. (2016) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-016-3398-y · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
- Authors
- Semkina, A. S., Abakumov, M. A., Grinenko, N. F., Lipengolts, A. A., Nukolova, N. V., & Chekhonin, V. P.
- Affiliations
- Pirogov Russian National Research Medical University (RU)
- National University of Science and Technology (RU)
- Ministry of Health of the Russian Federation (RU)
- Russian Cancer Research Center NN Blokhin (RU)
- Corresponding author
- Semkina, A. S.
- Venue
- Bulletin of Experimental Biology and Medicine
- Published
- 2017-04
- Volume
- 162
- Issue
- 6
- Pages
- 808-811
- ISSN
- 0007-4888 (ISSN-L)
- 1573-8221
- OpenAlex
- W2606617751
- Cited by
- 15
- References
- 10
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bulletin of Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- magnetic iron oxide nanoparticles, MRI contrast agents, tumor imaging, glioblastoma, mammary adenocarcinoma, tumor vascularization
- MeSH terms
- Adenocarcinoma, Animals, Brain Neoplasms, Adenocarcinoma, Mucinous, Contrast Media, Female, Ferric Compounds, Glioma, Injections, Subcutaneous, Liver Neoplasms, Magnetic Resonance Imaging, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Rats, Wistar, Cell Line, Tumor, Mice, Rats, Magnetite Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
